Abstract
Objectives
To investigate the value of magnetization transfer (MT) MRI and texture analysis (TA) of T2-weighted MR images (T2WI) in the assessment of intestinal fibrosis in a mouse model.
Methods
Chronic colitis was induced in mice by cyclic administration of dextran sodium sulphate (DSS) resulting in chronic inflammation and progressive bowel fibrosis. Mice underwent 7-T MR imaging at various time points. Bowel wall MT ratio (MTR) and textural features (skewness, kurtosis, entropy), extracted by a filtration histogram technique, were correlated with histopathology. Performance of both techniques were validated using antifibrotic therapy. Finally, a retrospective study was conducted in five patients with Crohn’s disease (CD) who underwent bowel surgery.
Results
MTR and texture entropy correlated with histopathological fibrosis (r = .85 and .81, respectively). Entropy was superior to MTR for monitoring bowel fibrosis in the presence of coexisting inflammation (linear regression R2 = .93 versus R2 = .01). Furthermore, texture entropy was able to assess antifibrotic therapy response (placebo mice versus treated mice at endpoint scan; Δmean = 0.128, p < .0001). An increase in entropy was indicative of fibrosis accumulation in human CD strictures (inflammation: 1.29; mixed strictures: 1.4 and 1.48; fibrosis: 1.73 and 1.9).
Conclusion
MT imaging and TA of T2WI can both noninvasively detect established intestinal fibrosis in a mouse model. However, TA is especially useful for the longitudinal quantification of fibrosis in mixed inflammatory-fibrotic tissue, as well as for antifibrotic treatment response evaluation. This accessible post-processing technique merits further validation as the benefits for clinical practice as well as antifibrotic trial design would be numerous.
Key Points
• Magnetization transfer MRI and texture analysis of T2-weighted MR images can detect established bowel fibrosis in an animal model of gut fibrosis.
• Texture entropy is able to identify and monitor bowel fibrosis progression in an inflammatory context and can assess the response to antifibrotic treatment.
• A proof-of-concept study in five patients with Crohn’s disease suggests that texture entropy can detect and grade fibrosis in human intestinal strictures.
Similar content being viewed by others
Abbreviations
- CD:
-
Crohn’s disease
- DAI:
-
Disease Activity Index
- DSS:
-
Dextran sulfate sodium
- IncrEn:
-
Incremental entropy
- MRE:
-
MR enterography
- MT:
-
Magnetization transfer
- MTR:
-
Magnetization transfer ratio
- NormEn:
-
Normalized entropy
- T2WI:
-
T2-weighted images
- TA:
-
Texture analysis
- TI:
-
Terminal ileum
References
Zhong YK, Lu BL, Huang SY et al (2020) Cross-sectional imaging for assessing intestinal fibrosis in Crohn’s disease. J Dig Dis 21(6):342–350
Higgins PD (2017) Measurement of fibrosis in Crohn’s disease strictures with imaging and blood biomarkers to inform clinical decisions. Dig Dis 35(1–2):32–37
Rieder F, Latella G, Magro F et al (2016) European Crohn’s and Colitis Organisation topical review on prediction, diagnosis and management of fibrostenosing Crohn’s disease. J Crohns Colitis 10(8):873–885
Bettenworth D, Bokemeyer A, Baker M et al (2019) Assessment of Crohn’s disease-associated small bowel strictures and fibrosis on cross-sectional imaging: a systematic review. Gut 68(6):1115–1126
Maaser C, Sturm A, Vavricka SR et al (2019) ECCO-ESGAR guideline for diagnostic assessment in IBD Part 1: Initial diagnosis, monitoring of known IBD, detection of complications. J Crohns Colitis 13(2):144–164
Rimola J, Planell N, Rodriguez S et al (2015) Characterization of inflammation and fibrosis in Crohn’s disease lesions by magnetic resonance imaging. Am J Gastroenterol 110(3):432–440
Adler J, Swanson SD, Schmiedlin-Ren P et al (2011) Magnetization transfer helps detect intestinal fibrosis in an animal model of Crohn disease. Radiology 259(1):127–135
Pazahr S, Blume I, Frei P et al (2013) Magnetization transfer for the assessment of bowel fibrosis in patients with Crohn’s disease: initial experience. MAGMA 26(3):291–301
Adler J, Rahal K, Swanson SD et al (2013) Anti-tumor necrosis factor alpha prevents bowel fibrosis assessed by messenger RNA, histology, and magnetization transfer MRI in rats with Crohn’s disease. Inflamm Bowel Dis 19(4):683–690
Dillman JR, Swanson SD, Johnson LA et al (2015) Comparison of noncontrast MRI magnetization transfer and T2 -weighted signal intensity ratios for detection of bowel wall fibrosis in a Crohn’s disease animal model. J Magn Reson Imaging 42(3):801–810
Li XH, Mao R, Huang SY et al (2018) Characterization of degree of intestinal fibrosis in patients with Crohn disease by using magnetization transfer MR imaging. Radiology 287(2):494–503
Meng J, Huang S, Sun C et al (2020) Comparison of three magnetization transfer ratio parameters for assessment of intestinal fibrosis in patients with Crohn’s disease. Korean J Radiol 21(3):290–297
Fang ZN, Li XH, Lin JJ et al (2020) Magnetisation transfer imaging adds information to conventional MRIs to differentiate inflammatory from fibrotic components of small intestinal strictures in Crohn’s disease. Eur Radiol 30(4):1938–1947
Makanyanga J, Ganeshan B, Rodriguez-Justo M et al (2017) MRI texture analysis (MRTA) of T2-weighted images in Crohn’s disease may provide information on histological and MRI disease activity in patients undergoing ileal resection. Eur Radiol 27(2):589–597
Bhatnagar G, Makanyanga J, Ganeshan B et al (2016) MRI texture analysis parameters of contrast-enhanced T1-weighted images of Crohn’s disease differ according to the presence or absence of histological markers of hypoxia and angiogenesis. Abdom Radiol (NY) 41(7):1261–1269
Tabari A, Kilcoyne A, Jeck WR, Mino-Kenudson M, Gee MS (2019) Texture analysis of magnetic resonance enterography contrast enhancement can detect fibrosis in Crohn disease strictures. J Pediatr Gastroenterol Nutr 69(5):533–538
Miles KA, Ganeshan B, Hayball MP (2013) CT texture analysis using the filtration-histogram method: what do the measurements mean? Cancer Imaging 13(3):400–406
Goh V, Ganeshan B, Nathan P, Juttla JK, Vinayan A, Miles KA (2011) Assessment of response to tyrosine kinase inhibitors in metastatic renal cell cancer: CT texture as a predictive biomarker. Radiology 261(1):165–171
Ng F, Ganeshan B, Kozarski R, Miles KA, Goh V (2013) Assessment of primary colorectal cancer heterogeneity by using whole-tumor texture analysis: contrast-enhanced CT texture as a biomarker of 5-year survival. Radiology 266(1):177–184
Rieder F, Fiocchi C, Rogler G (2017) Mechanisms, management, and treatment of fibrosis in patients with inflammatory bowel diseases. Gastroenterology 152(2):340–50 e6
Jairath V, Levesque BG, Vande Casteele N et al (2017) Evolving concepts in phases I and II drug development for Crohn’s disease. J Crohns Colitis 11(2):246–255
Van Welden S, De Vos M, Wielockx B et al (2017) Haematopoietic prolyl hydroxylase-1 deficiency promotes M2 macrophage polarization and is both necessary and sufficient to protect against experimental colitis. J Pathol 241(4):547–558
Holvoet T, Devriese S, Castermans K et al (2017) Treatment of intestinal fibrosis in experimental inflammatory bowel disease by the pleiotropic actions of a local Rho kinase inhibitor. Gastroenterology 153(4):1054–1067
Kanda T, Nakai Y, Oba H, Toyoda K, Kitajima K, Furui S (2016) Gadolinium deposition in the brain. Magn Reson Imaging 34(10):1346–1350
Li XH, Sun CH, Mao R et al (2015) Assessment of activity of Crohn disease by diffusion-weighted magnetic resonance imaging. Medicine (Baltimore) 94(43):e1819
Wilkens R, Hagemann-Madsen RH, Peters DA et al (2018) Validity of contrast-enhanced ultrasonography and dynamic contrast-enhanced MR enterography in the assessment of transmural activity and fibrosis in Crohn’s disease. J Crohns Colitis 12(1):48–56
Catalano OA, Gee MS, Nicolai E et al (2016) Evaluation of quantitative PET/MR enterography biomarkers for discrimination of inflammatory strictures from fibrotic strictures in Crohn disease. Radiology 278(3):792–800
Acknowledgements
The antifibrotic compound (REDX08397) that was used in this study was provided by Redx Pharma Plc.
Statistical analyses were performed by Dr Ellen Deschepper (Biostatistics Unit, Ghent University, Ghent, Belgium).
Histopathologic evaluation was co-executed by professor emeritus Dr Karel Geboes (University Hospital KULeuven, Leuven, Belgium).
Figures were partially created with BioRender.
Funding
This study was supported by research grants from the Department of Radiology and Medical Imaging, Ghent University Hospital, Ghent, Belgium. Sophie Van Welden is supported by a fellowship from Ghent University, Ghent, Belgium [BOF20/PDO/047].
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Guarantor
The scientific guarantor of this publication is Prof Dr Debby Laukens.
Conflict of interest
Peter Bunyard is an employee of Redx Pharma Plc but had no control of the data nor control of information that might present a conflict of interest. The other authors of this manuscript declare no relationships with any companies, whose products or services may be related to the subject matter of the article.
Statistics and biometry
Dr Ellen Deschepper provided statistical advice for this manuscript and performed statistical analyses.
One of the authors, Simon Bos, has significant statistical expertise.
Informed consent
Written informed consent was waived because of the retrospective nature of the proof-of-concept study.
Ethical approval
The proof-of-concept study was approved by the Ethics Committee of Ghent University Hospital (EC/2018/1493, Belgian study registration number B670201838339). Approval from the institutional animal care committee was obtained.
Methodology
•Animal study: prospective; human proof-of-concept study: retrospective
•Experimental
•Performed at one institution
Additional information
Publisher's note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Isabelle De Kock and Simon Bos share equal first authorship contribution.
Geert Villeirs and Debby Laukens share equal senior authorship contribution.
Supplementary Information
Below is the link to the electronic supplementary material.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
De Kock, I., Bos, S., Delrue, L. et al. MRI texture analysis of T2-weighted images is preferred over magnetization transfer imaging for readily longitudinal quantification of gut fibrosis. Eur Radiol 33, 5943–5952 (2023). https://doi.org/10.1007/s00330-023-09624-x
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00330-023-09624-x